Form D · Biotechnology
JangoBio, LLC
Fitchburg, WI · CIK 0001803661
Offering snapshot reported Jun 16, 2020 · SEC filing
- Reported sold
- $2.44M Offering amount: $2.44M
- Investors reported
- 72 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 14, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 16, 2020 | Initial | $2,435,366 | No comparison | 72 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-369088
Source: Form D, filed Jun 16, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Craig S. Atwood | Director, Executive, Promoter |
| Richard Bowen | Director |
| Robert Cramer | Director |
| William Kohl | Director, Executive |
| Victor Mohoney | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Attn: Craig S. Atwood, Ph.D, Ceo 2997 Yarmouth Greenway Dr.
Fitchburg, WI, 53711
Fitchburg, WI, 53711